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The nondefective strains of Rous sarcoma virus (RSV) 1 derived from the original Rous 
chicken tumors  (1)  are known to contain both transforming and replicating functions 
(2-4, 4a). With relatively high frequencies, these sarcoma viruses spontaneously convert 
to transformation defective (td) mutants which retain only replicating functions (5, 6). 
The genomic RNA of the td mutants is about 15% smaller than the parental RSV RNA, 
corresponding to the loss of ~ 1,500 nucleotides  (7-10).  The analysis of oligonucleotides 
obtained after hydrolysis of the RNAs of parental RSV and of td mutants showed that 
the deletions occur in a specific portion of the RSV genome, located near the 3' terminus 
(11, 12). Since this particular segment of the genome, deleted in td virus RNA, is also 
absent in naturally occurring nonsarcomagenic oncoviruses (avian leukosis viruses), it 
is thought to be responsible for sarcomagenic transformation, and was designated as the 
src gene (13-15). 
The size of the deletions in td mutants has been considered to be relatively uniform 
(8, 15a). However, recent studies by us and others suggested the existence of some varia- 
tions  (16, 17;  M.  C.  Lai,  S.  Hu,  and  P.  K.  Vogt,  personal  communication).  Certain 
isolates of td  mutants of the Schmidt-Ruppin strain of RSV  (SR-RSV-A), which were 
found to contain RNA slightly larger than that of other td mutants and leukosis viruses, 
were  able to interact with  an  RSV  mutant  which  is temperature-sensitive in  trans- 
formation to form a  recombinant with  a  reduced  temperature-sensitivity  (17). Thus, 
these td mutants appear to retain a small portion of the src gene which is not sufficient to 
cause cell transformation in vitro. 
As part of the survey of characteristics of these partially deleted td mutants, 
we examined their potential to produce tumors in chickens.  In this paper, we 
will report that some of the td mutants were capable of producing sarcomas in 
chickens after an unusually long latent period at sites distant from the original 
injection,  and that fully transforming sarcoma virus was recovered from every 
one of these tumors.  Evidence will be presented that this tumor production is 
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not  due  to  contamination of the  td  virus  preparations  by parental  strain  of 
RSV. The formation of the new sarcoma virus is, therefore, most likely a  result 
of genetic  interaction between  the  td  virus  and  some host cell  component in 
chickens. 
Materials  and Methods 
Virus.  Isolation of td mutants was described (6, 17). These td viruses were present in a stock 
of SR-RSV-A  as spontaneous deletion mutants and were isolated by cloning. The td virus stocks 
contained generally  -107 infectious units per ml.  The preparations  of Rous-associated virus-1 
(RAV-1) and SR-RSV-A  have been described before (6, 18). Avian erythroblastosis  virus,  strain 
ES4, was kindly provided by Dr. R. Ishizaki, Duke University,  Durham, N. C. 
Cells.  Chicken embryo fibroblasts used were prepared from fertile eggs obtained from a flock 
free  of group-specific (gs) antigens  (SPAFAS, Inc.,  Norwich,  Conn.). These  cells  were  also 
negative for chicken helper factor (chf). Conditions for cell culture and virus titration have been 
described (19, 20). 
Chickens.  Two flocks of chickens  (SPAFAS, Inc.) were  used. One flock is called COFAL- 
negative and another GS-negative. Both flocks are free of avian leukosis virus but -30% of the 
COFAL-negative chickens are positive for the expressions of gs antigen and chf, whereas chickens 
of the GS-negative flock are almost entirely free (>95%) of these expressions (21). 
Inoculation of Chickens.  0.1 ml (containing -106 infectious units) of cell-free virus in culture 
medium was inoculated into wing webs for testing  sarcoma formation. Injections were usually 
subcutaneous  but due to the wing size of baby chicks some may have  been intramuscular  or 
intravenous.  Chickens were examined by palpation for the presence of tumors  every 3-4 days. 
When tumors  were removed, they were cut into small pieces. A portion was formalin-fixed for 
pathological examination,  a portion was frozen for later homogenization, and the remainder was 
trypsinized in the same manner as used for preparing  primary cultures  of chicken embryo cells 
(20). The trypsinized tumor cells were plated into tissue culture  dishes with or without addition 
of normal chicken embryo cells. 
Results 
As described previously, td mutants isolated from SR-RSV-A were shown to 
be  free  of detectable  transforming  virus  in  repeated  tests  examining  either 
direct cell transformation or the production of transforming virus  (17).  In the 
first  attempt of this series  (exp.  1,  Table  I),  we inoculated these tested  virus 
stocks of tdl01, 105,  107, and 108 into the wing web of newborn chicks (within 1 
day). As expected, no sarcomas were produced at the site of injection. However, 
solid tumors were recognized in several chickens  (exp.  1,  Table I) between 61 
and 68 days after infection at sites distant from the original injection,  such as 
breast,  legs,  or back.  When tumor cells were co-cultured with normal chicken 
embryo fibroblast  cells,  cultures  became transformed  within  a  few days  and 
displayed morphological characteristics similar to those of cells transformed by 
RSV.  We observed,  however, that the morphology of both foci and individual 
transformed cells  induced by these  recovered agents  was  different from that 
induced by SR-RSV (see below). High titers of transforming virus (>105 focus- 
forming units per ml) were obtained from co-culture-derived transformed cells. 
Transforming virus  was  also  recovered  by  direct  homogenization of tumors, 
and 20% tumor homogenates contained 103-105 focus-forming units per ml. The 
virus recovered produced sarcomas within 10 days upon injection into 1-wk-old 
chickens.  These  preliminary  experiments  strongly  suggested  that  some  td 
mutants were capable of producing solid tumors aider a  long latent period, and H.  HANAFUSA,  C.  C.  HALPERN,  D.  L.  BUCHHAGEN,  AND  S.  KAWAI 
TABLE  I 
Formation of Solid Tumors by td Mutants of SR-RSV-A 
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Number of  ehickensll 
Virus  State of  purifi-  Fleck of  chick-  Route of  injec-  Dead 
cation*  ens$  tions§  Total  With solid  without  Remained 









tdl01  Purified 
tdl01  Purified 
tdl07A  Purified 
tdl08  Purified 
tdl08  Purified 
tdl09 
tdl01  Purified 
tdl01  Purified 
tdl07A  Purified 




COFAL  s.c.  5  2  0  3 
COFAL  s.c.  5  1  0  4 
COFAL  s.c.  4  2  1  1 
COFAL  s.c.  4  3  0  1 
COFAL  s.c.  8  0  2  6 
COFAL  s.c,  8  2  6  0 
GS  s.c.  8  2  4  2 
COFAL  s~c.  8  0  4  4 
COFAL  s.c.  8  4  4  0 
OS  s.c.  8  5  3  0 
COFAL  s.c.  8  4  3  1 
GS  i.v.  7  6  1  0 
GS  i.m.  8  5  3  0 
GS  i.v.  8  0  3  5 
GS  i.m.  7  0  2  5 
GS  i.m.  8  0  3  5 
GS  i.m.  7  2  2  3 
GS  i.m.  8  0  0  8 
* Some td mutants were "repurified" by one or more additional  terminal dilution  passages. 
Two chicken flocks designated as COFAL-negative  and GS-negative  were used. 
§ s.c., subcutaneous;  i.m., intramuscular; i.v., intravenous. 
II All chickens in these experiments  were injected within  1 day after hatching.  Observations  were terminated  at 13 wk in exps.  1 
and 2, and at 14 wk in exp. 3. 
that the resulting tumors produce transforming virus which is similar to RSV 
in many respects. 
Further Purification  of td Viruses  and  Their Specificity of Tumor Produc- 
tion.  Although  the original td virus preparations were repeatedly tested for 
the  absence  of transforming  virus  and  have  been  shown to  contain  genomic 
RNA similar in size to those ofnontransforming oncoviruses (17), the possibility 
still remained that tumors were induced by very minute amounts of SR-RSV 
existing as contaminants in the td virus preparation.  Such contaminants may 
have escaped detection due to the presence of a large excess of nontransforming 
virus  which  could  cause  viral  interference.  To  eliminate  such  a  possible 
contaminant,  chicken  cells  were  infected  with  serial  10-fold  dilutions  of td 
virus  stocks  (tdl01,  107,  108),  and  virus  was  recovered after three transfers 
from terminal  dilutions  (10  -6  for  all  three)  which gave  positive  interference 
against  SR-RSV-A.  For  tdl01,  purification  by  this  terminal  dilution  was 
repeated twice. As shown in Table I (exps. 2 and 3), tdl01 and 108 were active 
in tumor production after this purification. All tumors except one (12 wk) were 
found at 8-9 wk after injection.  Unpurified tdl09 was also found to be active in 
tumor production (exp. 2). 
On the other hand,  tdl07,  which was recovered from the terminal dilution, 
lost its tumor-inducing activity.  This was anticipated from the composition of 
viral  RNA  of tdl07  analyzed  by  gel  electrophoresis  (17)  which  showed  the 
presence of two RNA components in tdl07,  a  minor component of larger-sized 
RNA  and a  major component of smaller-sized  RNA.  If the ratio of these two 1738  FORMATION  OF  NEW  AVIAN  SARCOMA  VIRUS 
RNA components reflected the ratio of virus particles containing these two size 
classes of RNA, and if the virus containing the larger-sized RNA was respon- 
sible for tumor formation, then the tumor-producing component may have been 
selected against by the terminal dilution. To distinguish between the original 
tdl07  preparation  and the recloned virus,  tdl07  obtained from the terminal 
dilution which was negative in tumor formation will be designated tdl07A. In 
addition to tdl07A, tdl06 was negative in tumor formation in one experiment 
with a limited number of animals. Control chickens, which received either 0.1 
ml of RAV-1  (exp.  2),  or unused tissue culture fluid (exp.  3)  did not develop 
solid tumors within the 14-wk-period of observation. 
In both the second and third experiments, a  significant fraction of chickens 
died because of either poor development, enlargement of the heart,  liver,  or 
kidneys, or without an identifiable symptom. The deaths were apparently due to 
td virus infection as none of  the control chickens (exp 3) died, but we have made 
no further attempt to examine the cause of death. Lymphoid leukosis is known 
to appear rarely before 14 wk of age (22). 
A comparison was made between chickens of two flocks termed gs antigen- 
negative and COFAL-negative. No  significant difference was found between 
the two types of chickens in the frequency of tumor formation by tdl01 and 108, 
indicating that endogenous viral information responsible for the expression of 
gs antigen and chf is not directly related to the tumor formation by td viruses. 
The  route  of injection  does  not  seem  to  be  an  important  factor  in  the 
frequency  of tumor  formation.  However,  the  comparison  of various  routes 
(Table I) was not conclusive since both subcutaneous and intravenous injections 
sometimes resulted in the leakage of inoculum to surrounding muscle tissues 
due to either the size of the wing webs or the fragility of the blood vessel of the 
newborn chicks. 
Pathological Findings.  Tumors appeared in various parts of the body: often 
in the  leg,  wing,  chest,  or back,  and organs  such as  the kidney, liver,  and 
heart.  We also found malignant growths in the abdominal cavity and tissues 
surrounding the eye. Frequently, more than one tumor was found in a  single 
chicken. The size of tumors was variable but was sometimes larger than 3 cm 
in diameter. Histologically, the tumors consisted predominantly of sarcomas- 
possibly  of muscle  origin-and  were  oi~en  associated  with  hemorrhage  or 
necrotic areas.  It seems clear that primary tumors were produced at various 
sites in the injected chickens. In two cases kidney tumors were associated with 
areas of nephroblastomas. However, some tumors in internal organs seemed to 
have been formed secondarily by metastasis. 
Transforming virus  was  recovered  from  most  of these  tumors,  including 
kidney tumors. Thus far no difference was found in the morphology of trans- 
formed cells induced by these virus isolates. 
Some  Characteristics  of Recovered  Transforming  Viruses.  Transforming 
virus was recovered from all 18 tumors examined. All isolates thus far tested 
(12 samples) were capable of producing sarcomas in the wing web of chickens 
at a rate comparable to Bryan or Schmidt-Ruppin strains of RSV. Therefore we 
will call the new isolates collectively '~recovered avian sarcoma virus" (r-ASV) 
and individual isolates will be distinguished by the number of the tumor from 
which the virus was recovered. H.  HANAFUSA,  C.  C.  HALPERN,  D.  L.  BUCHHAGEN,  AND  S.  KAWAI  1739 
The  r-ASV  isolates  were  indistinguishable  from  SRoRSV-A  and  the  td 
mutants in subgroup specificity, as shown both by the specificity of interference 
and  antigenic determinants.  It  was  somewhat surprising  to  find that  some 
isolates of r-ASV did not contain td virus in concentrations higher than r°ASV. 
In preliminary attempts, most loci made by such isolates (r°ASV 50 and 165) 
were found to produce infectious transforming virus, suggesting that at least 
these isolates are nondefective. 
The focus morphology of the r-ASV-transformed cells is shown in Fig.  1 in 
comparison with that of SR-RSV°A transformed cells.  It  is  remarkable that 
there was very little, if any, difference in the morphology of foci produced by 
the isolates of r°ASV recovered from many different tumors. The foci of r°ASV 
generally consisted  of small,  round  transformed cells  tightly held together 
(Fig. 1 A-D). Thus, r-ASV-induced transformed cells were readily distinguish- 
able from loci of SR-RSV-transformed cells, which are often spindle-shaped and 
scattered over the layer of normal cells into a  relatively large area (Fig.  1 E, 
F).  Foci  induced  by  r°ASV  often  have  an  area  of cell  displacement,  thus 
making a  small  hole,  the  extent of which perhaps  exceeds  similar changes 
often  seen  with  the  Bryan  strains  of RSV.  Because  of this  effect,  r-ASV- 
transformed cells had a  tendency to detach from the substratum when these 
transformed cells became the majority of the cell population in a culture. 
There seem to exist variations in the virus titer depending on the original td 
virus samples.  High titers of virus  (0.2-2  ×  10  ~ focus-forming virus per  ml) 
were uniformly recovered from tumors induced by tdl01.  On the other hand, 
relatively low titers of virus (4  ×  10  l, 6  ×  101, 3.3  ×  102, and 7.8  ×  103 focus- 
forming units per ml) were obtained from tumors induced by tdl09. 
Discussion 
Genetic  interaction  between  leukosis  type  virus  and  host  cell  genes  has 
recently  attracted  attention  as  a  possible  mechanism  for  the  formation of 
sarcoma-inducing viruses.  First,  most strains of murine sarcoma virus were 
obtained from tumors experimentally developed after serial passage of  leukemia 
virus in rats or mice  (23-26).  Molecular hybridization analysis revealed that 
specific sequences,  that were gained by these sarcoma viruses,  and are thus 
apparently responsible for sarcomagenic transformation by these viruses, are 
of cellular origin. The specific sequences of rat-derived sarcoma virus are not 
homologous to those of mouse-derived virus, and the specific sequences of each 
virtls are homologous to cellular DNA of their respective animal species  (27- 
32). Second, all avian sarcoma viruses have been obtained from tumors found 
in the field. No example of the derivation of avian sarcoma virus from leukosis 
virus has been reported. However, the presence of genetic information specific 
to the src gene of RSV has been demonstrated within DNA and RNA of normal 
tissues of various avian species by molecular hybridization (15, 33, 34). Third, 
in addition to these endogenous src  genes, chicken cells are known to contain 
endogenous oncovirus genetic information which is homologous to other por- 
tions of oncovirus genome (35-37).  Genetic recombination of these endogenous 
viral genes with exogenously infected leukosis viruses has been shown to yield 
a new leukosis-type virus, RAV-60,  with the envelope glycoprotein gene specific 





o 1742  FORMATION  OF  NEW  AVIAN  SARCOMA  VIRUS 
In a previous study, we found that the src gene in some of the td mutants of 
SR-RSV  is  only  partially  deleted  (17).  If  recombination  with  endogenous 
(cellular) sarcoma-specific sequences is the key to the genesis of sarcoma virus, 
these partially retained src sequences of td mutants may greatly facilitate an 
interaction that would increase the frequency of formation of sarcoma virus. 
This  consideration was  the  rationale  behind  our  first attempts  to  generate 
sarcoma viruses by inoculation of  td virus into 1-day-old chickens in this study. 
The formation of tumors and the recovery of sarcoma-inducing virus, how- 
ever, might be attributed to other more trivial reasons. First, parental SR-RSV 
might  still  be  present  at  very  low  titer  in  td  virus  preparations,  and  be 
responsible for these phenomena. This seems, however, highly unlikely for a 
number of reasons.  The original isolates of each td  mutant have been exten- 
sively tested  for  focus-forming virus  in  tissue  culture  (17). The  absence  of 
tumor formation at the site of inoculation in this study can be considered as 
another  line  of evidence for the  absence  of transforming virus,  since  other 
experiments by us showed that tumor formation was at least as sensitive as 
focus formation in tissue culture for detection of infectious SR-RSV-A particles. 
Furthermore, we have purified the td viruses by the limiting dilution method 
in which final virus stocks  were  isolated from cultures infected with a  10  -6 
dilution of the original stock. The presence of l0  T infectious units of nontrans- 
forming  virus  (RAV  or  td  virus)  per  106  cells  is  known  to  cause  70-90% 
suppression of infection by simultaneously added RSV (18). Thus, the failure to 
detect focus-forming virus in the td  mutant stocks  (1  ml)  indicates that the 
titer of RSV, if any, in the original td virus stocks was not >10 focus-forming 
units per ml. The probability of recovering RSV in the cultures infected with a 
10  .6 dilution of a  td virus stock would then be below 10  -5.  tdl01  was further 
purified by repeating this procedure. The fact that tdl07A was no longer active 
in  tumor  induction demonstrated that  the  limiting dilution procedure  does 
effectively eliminate a smaller component from a mixture of viruses. 
If the  tumors  were  formed  by  a  contaminant  SR-RSV,  we  should  have 
recovered SR-RSV from the tumors. As shown in Fig. 1, the loci formed by all 
of the r-ASV isolated had similar morphologies, but were quite different from 
those of SR-RSV. 
One might argue that some of the td mutants are not deleted within the src 
gene,  but  contain point mutations; the  difference in the  size  of the RNA of 
these mutants could be deletions in other portions of the genome. In this case, 
spontaneous reversion of the point mutations could be responsible for tumor 
formation. Experiments described in this paper do not exclude this possibility. 
However, preliminary experiments analyzing the content of src gene informa- 
tion in the  RNA  of td  mutants seems  to  indicate that the  deletions indeed 
occurred  within the src  gene.  For example,  DNA  complementary to the src 
gene of SR-RSV hybridized only 22% with tdl01 RNA. (W. S. Hayward and H. 
Hanafusa, unpublished results). 
As another explanation, one can consider that infection by td  virus might 
have induced an endogenous sarcoma virus. However, the endogenous src gene 
and the other viral genes essential for replication are apparently integrated 
into different chromosomes of normal chicken cells (40). Thus, the formation of 
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the differences in the virus titers of r-ASVs recovered from tumors induced by 
tdl01  and  109  suggests that some properties of r-ASV  are dependent on the 
original td  virus.  The fact that r-ASV belongs to the same subgroup A  as td 
viruses  also  supports  the  above  suggestion,  since  the  endogenous  viral  se- 
quences in chicken cells appear to contain only subgroup E specific information 
for envelope glycoproteins (36-38). 
Thus, tumor formation by td  virus and the recovery of r-ASV  can be best 
explained by an assumption that td mutants which contain partial deletions in 
the src  gene become converted to r-ASV  after genetic interaction with some 
host  cell  component.  Preliminary  studies  2  indicate  that  the  RNA  of some 
isolates of r-ASV is in fact restored to the size of the RNA of SR-RSV. Whether 
or not this is due to recombination with the cellular sarcoma-specific sequences 
should be clarified by a comparison of the sequences of the src genes of r-ASV, 
SR-RSV, and chicken cells. 
The  recovered  virus  is  considered to  be  a  sarcoma virus,  based  on  many 
characteristics of in vitro and in vivo infection. Avian erythroblastosis virus is 
known to produce  sarcomas by injection into the wing web,  and causes cell 
transformation in fibroblast cultures (41, 42). However, sarcoma production by 
r-ASV  was  much  faster  and  more  consistent than  that  by  erythroblastosis 
virus. Infection by the latter virus often results in erythroblastosis (8-10  days 
after infection) before sarcomas are formed (42). Within the 3-wk observation 
period,  chickens inoculated with r-ASV produced sarcomas but none of them 
developed  erythroblastosis.  Finally, r-ASV  caused  more  readily identifiable 
cell transformation in fibroblast cultures than erythroblastosis virus. 
We have previously demonstrated that some td mutants can recombine with 
a  temperature-sensitive mutant of RSV, TS68,  and have considered this to be 
evidence for the presence of a  partial src gene in these mutants (17). The fact 
that all of these mutants, tdl07, 108, and 109, were capable of producing r-ASV 
supported this idea. However, some mutants, tdl01 and 105, were negative for 
recombination with TS68 and yet positive for r-ASV formation. This may be a 
result of the requirement of a specific region of the src gene in the td mutant to 
replace  the  TS  lesion of TS68,  whereas  recombination with the  cellular src 
gene may not require a specific set of src sequences in the td mutants. 
In general,  the  size of td  virus RNA described in the previous paper  (17) 
correlated with its tumor-producing capacity. The td viruses with larger RNA, 
tdl07 and 108, were tumorigenic whereas tdl06 was not. However, tcll01 and 
109, which were shown to be similar to a standard td virus in the size of RNA, 
were active in the formation of r-ASV. The reexamination of the size of these 
td  virus  RNAs  and  their  correlation  with  the  recovery  of r-ASV  will  be 
described elsewhere together with more detailed properties of some of the r- 
ASV isolates. 
The period required for the tumor formation after injection with td  viruses 
would be  shorter than 60 days if chickens were examined by autopsy rather 
than by palpation. If one assumes that tumor formation was initiated by r-ASV 
after it had been generated and that the tumor formation required about 15 
days, then the time period required for the generation of r-ASV would be about 
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45 days.  The  requirement  of this long period could be a  reflection of the fact 
that  genetic  interactions  leading  to  the  formation  of a  stable  recombinant 
between td virus and cellular genes is a relatively rare event. But, at the same 
time,  it occurs rather  consistently as shown by the formation of tumors in a 
high percentage of td virus-infected chickens. 
Transforming  virus  has  not  been  detected  in  tissue  culture  cells  infected 
with td virus.  Murine sarcoma viruses have also been obtained only after the 
passage of leukemia virus in vivo. It remains to be determined whether this is 
due to a  difficulty in performing such long-term experiments in tissue culture, 
to  much  greater  numbers  of cells  involved  in  in  vivo  infection,  to  higher 
susceptibility of neighboring  tissues  in  vivo to  immediate  transformation  by 
newly formed r-ASV  or  to  some  specific physiological  conditions  in  animals 
which are not available in tissue cultures. 
In studies of biological activities of avian leukosis viruses, occasional forma- 
tion of sarcomas in chickens has been described (20,  41,  43, 44),  but no report 
has been made of the direct recovery of a  typical sarcoma virus. In this study, 
RAV-1,  included  as  one  of the  controls,  did not  produce sarcomas.  It  seems 
clear  that  td  viruses  containing  a  partial  src  gene  have  an  advantage  over 
other  standard  leukosis  viruses  for  the  generation  of r-ASV.  A  26S  RNA 
containing  endogenous  (cellular)  src  genetic  information  was  identified  in 
normal chicken cells, and this RNA species does not contain sequences homolo- 
gous to other portions of the viral genome (45).  The presence of the partial src 
gene  in  td  virus  could  then  be  crucial  since  it  would  provide  homologous 
sequences which may be required  for recombination  with the endogenous src 
gene.  Further  studies  on this  system should  provide  information  concerning 
relationships  between the cellular src sequences, present in normal cells, and 
carcinogenesis. 
Summary 
Transformation-defective  (td) mutants of the Schmidt-Ruppin strain of Rous 
sarcoma  virus  (RSV),  which  contains  deletions  in  the  gene  responsible  for 
transformation  (src gene), are unable to transform chicken embryo fibroblasts 
in vitro.  Injection of some of these td mutants into newborn chickens resulted 
in  the  formation  of  sarcomas  from  which  sarcoma  virus  was  unfailingly 
recovered. The possibility that transforming  RSV was present in the td virus 
preparations was excluded by further purification of the td viruses. Morphology 
of the foci induced by the newly recovered sarcoma virus was distinct from that 
of foci induced by the parental  Schmidt-Ruppin  strain  of RSV. It is suggested 
that the new sarcoma virus was generated as a result of the genetic interaction 
between the genomes of td virus and chicken cells. 
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